Fund Companies Rights Offerings Managed Distributions Leveraged Funds IPOs Asset Classes CEF Advisors

My Fund Comparison
Initilizing list...

Tekla Healthcare Investors  as of 01/27/2015

NYSE / HQH Asset Class:  Sector Equity Funds 1 YR Lipper Avg:  10.42%

Growth of $10K

Avg Annual Total Return %
  10 YR 5 YR 1 YR YTD
Market Return 15.47% 32.96% 41.15% 9.75%
Lipper Pct. Rank 15 17 14 34
NAV Return 14.25% 25.93% 31.65% 5.04%
Lipper Pct. Rank 20 20 8 30
Premium/Discount History

Premium/Discount
10 YR Avg 5 YR Avg YTD Avg
-8.007% -7.140% 0.600%

NAV $33.12 Market Price $34.56
Net Change -$0.25 Market Change $0.09
Premium/Discount 4.35%
1 YR NAV Return 31.645%
1 YR NAV Rank 8
12-Mo Yield as of 12/31/2014 Yield Def
Income Only Yield 0.00%
Distribution Yield (Market) 7.05%
Managed Distribution Plan 
Most Recent Income Dividend $0.590
Ex-Div Date 11/24/2014
Most Recent Cap Gain Dividend $0.530
Ex-Div Date 2/27/2014
Dividend Frequency Quarterly
YTD Dividends $1.690
YTD Capital Gains $0.530
Inception Date 4/23/1987
Fund Advisor Tekla Capital Management LLC
Manager & Tenure Team Managed
Phone 800-451-2597
Website www.hqcm.com
Total Net Assets (mil) as of -- --
% Leveraged Assets as of 9/30/2014 --
Portfolio Turnover --
Mgmt Fees 0.960%
Expense Ratio 1.130%
Fund Objective
The Fund seeks long-term capital appreciation by investing primarily in securities of companies in the health services and medical technology (health care) industries ("Health care Companies").
Top Holdings (as of 9/30/2014)
Gilead Sciences Inc ORD 12.88%
Celgene Corp ORD 8.94%
Vertex Pharmaceuticals Inc ORD 5.28%
Alexion Pharmaceuticals Inc ORD 4.68%
Regeneron Pharmaceuticals Inc ORD 4.54%
Actavis PLC ORD 4.47%
Amgen Inc ORD 4.17%
Biogen Idec Inc ORD 3.76%
Biomarin Pharmaceutical Inc ORD 2.79%
Allergan Inc ORD 2.65%
Top Sectors (as of 9/30/2014)
Health Care 88.48%
Non Classified Equity 3.27%
Consumer Services 1.25%
Technology 0.92%
Industrials 0.40%

Image Map

Resources

Aberdeen Webcasts

Aberdeen Closed-End TV

CEF Connect

Bonds

National Association of
Publicly Traded Partnerships


REITs


SySys Logo

Lipper Logo
Powered by a SySys data & content management system.

© Thomson Reuters 2011. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.